FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038891714> ?p ?o ?g. }

• W2038891714 endingPage "146" @default.
• W2038891714 startingPage "139" @default.
• W2038891714 abstract "Cyclooxygenase-2 (COX-2) expression is up-regulated in several types of human cancers and has also been directly linked to carcinogenesis. To investigate the role of COX-2 in pancreatic cancer, we evaluated COX-2 protein expression in primary human pancreatic adenocarcinomas (n = 23) and matched normal adjacent tissue (n = 11) by immunoblot analysis. COX-2 expression was found to be significantly elevated in the pancreatic tumor specimens compared with normal pancreatic tissue. To examine whether the elevated levels of COX-2 protein observed in pancreatic tumors correlated with the presence of oncogenic K-ras, we determined the K-ras mutation status in a subset of the tumors and corresponding normal tissues. The presence of oncogenic K-ras did not correlate with the level of COX-2 protein expressed in the pancreatic adenocarcinomas analyzed. These observations were also confirmed in a panel of human pancreatic tumor cell lines. Furthermore, in the pancreatic tumor cell line expressing the highest level of COX-2 (BxPC-3), COX-2 expression was demonstrated to be independent of Erk1/2 activation. The lack of correlation between COX-2 and oncogenic K-ras expression suggests that Ras activation may not be sufficient to induce COX-2 expression in pancreatic tumor cells and that the aberrant activation of signaling pathways other than Ras may be required for up-regulating COX-2 expression. We also report that the COX inhibitors sulindac, indomethacin and NS-398 inhibit cell growth in both COX-2-positive (BxPC-3) and COX-2-negative (PaCa-2) pancreatic tumor cell lines. However, suppression of cell growth by indomethacin and NS-398 was significantly greater in the BxPC-3 cell line compared with the PaCa-2 cell line (P = 0.004 and P < 0.001, respectively). In addition, the three COX inhibitors reduce prostaglandin E(2) levels in the BxPC-3 cell line. Taken together, our data suggest that COX-2 may play an important role in pancreatic tumorigenesis and therefore be a promising chemotherapeutic target for the treatment of pancreatic cancer." @default.
• W2038891714 created "2016-06-24" @default.
• W2038891714 creator A5002909668 @default.
• W2038891714 creator A5016784879 @default.
• W2038891714 creator A5022726531 @default.
• W2038891714 creator A5031825011 @default.
• W2038891714 creator A5042026897 @default.
• W2038891714 creator A5042425812 @default.
• W2038891714 creator A5051059014 @default.
• W2038891714 creator A5055513935 @default.
• W2038891714 creator A5059529660 @default.
• W2038891714 creator A5064334333 @default.
• W2038891714 date "2000-02-01" @default.
• W2038891714 modified "2023-10-10" @default.
• W2038891714 title "Cyclooxygenase-2 expression in human pancreatic adenocarcinomas" @default.
• W2038891714 cites W1536681507 @default.
• W2038891714 cites W1587123510 @default.
• W2038891714 cites W1647640400 @default.
• W2038891714 cites W1648593433 @default.
• W2038891714 cites W1766737321 @default.
• W2038891714 cites W1800050944 @default.
• W2038891714 cites W1901924975 @default.
• W2038891714 cites W1966103571 @default.
• W2038891714 cites W1993592556 @default.
• W2038891714 cites W1995015279 @default.
• W2038891714 cites W1995215542 @default.
• W2038891714 cites W2014489897 @default.
• W2038891714 cites W2034679499 @default.
• W2038891714 cites W2038197749 @default.
• W2038891714 cites W2043707891 @default.
• W2038891714 cites W2049169085 @default.
• W2038891714 cites W2051686420 @default.
• W2038891714 cites W2054120144 @default.
• W2038891714 cites W2055386493 @default.
• W2038891714 cites W2061416606 @default.
• W2038891714 cites W2067023276 @default.
• W2038891714 cites W2067282267 @default.
• W2038891714 cites W2068776651 @default.
• W2038891714 cites W2075039358 @default.
• W2038891714 cites W2094752831 @default.
• W2038891714 cites W2096428903 @default.
• W2038891714 cites W2097997344 @default.
• W2038891714 cites W2108882705 @default.
• W2038891714 cites W2115014494 @default.
• W2038891714 cites W2117858791 @default.
• W2038891714 cites W2122953993 @default.
• W2038891714 cites W2127558096 @default.
• W2038891714 cites W2129733741 @default.
• W2038891714 cites W2162517111 @default.
• W2038891714 cites W2164034599 @default.
• W2038891714 cites W2409573180 @default.
• W2038891714 cites W41889774 @default.
• W2038891714 doi "https://doi.org/10.1093/carcin/21.2.139" @default.
• W2038891714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10657949" @default.
• W2038891714 hasPublicationYear "2000" @default.
• W2038891714 type Work @default.
• W2038891714 sameAs 2038891714 @default.
• W2038891714 citedByCount "272" @default.
• W2038891714 countsByYear W20388917142012 @default.
• W2038891714 countsByYear W20388917142013 @default.
• W2038891714 countsByYear W20388917142014 @default.
• W2038891714 countsByYear W20388917142015 @default.
• W2038891714 countsByYear W20388917142016 @default.
• W2038891714 countsByYear W20388917142017 @default.
• W2038891714 countsByYear W20388917142018 @default.
• W2038891714 countsByYear W20388917142019 @default.
• W2038891714 countsByYear W20388917142020 @default.
• W2038891714 countsByYear W20388917142021 @default.
• W2038891714 countsByYear W20388917142022 @default.
• W2038891714 countsByYear W20388917142023 @default.
• W2038891714 crossrefType "journal-article" @default.
• W2038891714 hasAuthorship W2038891714A5002909668 @default.
• W2038891714 hasAuthorship W2038891714A5016784879 @default.
• W2038891714 hasAuthorship W2038891714A5022726531 @default.
• W2038891714 hasAuthorship W2038891714A5031825011 @default.
• W2038891714 hasAuthorship W2038891714A5042026897 @default.
• W2038891714 hasAuthorship W2038891714A5042425812 @default.
• W2038891714 hasAuthorship W2038891714A5051059014 @default.
• W2038891714 hasAuthorship W2038891714A5055513935 @default.
• W2038891714 hasAuthorship W2038891714A5059529660 @default.
• W2038891714 hasAuthorship W2038891714A5064334333 @default.
• W2038891714 hasBestOaLocation W20388917141 @default.
• W2038891714 hasConcept C121608353 @default.
• W2038891714 hasConcept C126322002 @default.
• W2038891714 hasConcept C134018914 @default.
• W2038891714 hasConcept C181199279 @default.
• W2038891714 hasConcept C2777996000 @default.
• W2038891714 hasConcept C2778764654 @default.
• W2038891714 hasConcept C2779689624 @default.
• W2038891714 hasConcept C2780210213 @default.
• W2038891714 hasConcept C2781182431 @default.
• W2038891714 hasConcept C502942594 @default.
• W2038891714 hasConcept C54355233 @default.
• W2038891714 hasConcept C55493867 @default.
• W2038891714 hasConcept C555283112 @default.
• W2038891714 hasConcept C71924100 @default.
• W2038891714 hasConcept C81885089 @default.
• W2038891714 hasConcept C86803240 @default.

• next